Clinical Trial Update: An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An IIT Phase 1 study to evaluate the safety, tolerability, and preliminary efficacy of a single intrathecal injection of SNUG01 in patients with Amyotrophic Lat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• SNUG01 (SNUG01)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Amyotrophic Lateral Sclerosis (ALS) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING